EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review

Kaitlyn Alleman, Erik Knecht iD, Jonathan Huang iD, Lu Zhang, Sandi Lam, Michael DeCuypere iD

Cancers · 16.01.2023 · 15 (2) · 545

DOI: 10.3390/cancers15020545 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.01.2023. Verfasst von Kaitlyn Alleman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chicago Medical School, Rosalind Franklin University of Science and Medicine, Chicago, IL 60064, USA. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant brain tumors pose a substantial burden on morbidity and mortality. As clinical data collection improves, along with the capacity to analyze it, novel predictive clinical tools may improve prognosis prediction. Deep learning (DL) holds promise for integrating clinical data of various modalities. A systematic review of the DL-based prognostication of gliomas was performed using the Embase (Elsevier), PubMed MEDLINE (National library of Medicine), and Scopus (Elsevier) databases, in accordance with PRISMA guidelines. All included studies focused on the prognostication of gliomas, and predicted overall survival (13 studies, 81%), overall survival as well as genotype (2 studies, 12.5%), and response to immunotherapy (1 study, 6.2%). Multimodal analyses were varied, with 6 studies (37.5%) combining MRI with clinical data; 6 studies (37.5%) integrating MRI with histologic, clinical, and biomarker data; 3 studies (18.8%) combining MRI with genomic data; and 1 study (6.2%) combining histologic imaging with clinical data. Studies that compared multimodal models to unimodal-only models demonstrated improved predictive performance. The risk of bias was mixed, most commonly due to inconsistent methodological reporting. Overall, the use of multimodal data in DL assessments of gliomas leads to a more accurate overall survival prediction. However, due to data limitations and a lack of transparency in model and code reporting, the full extent of multimodal DL as a resource for brain tumor patients has not yet been realized.

Schlagwörter

Stichwörter der Autor:innen

brain tumordeep learninggenomicsgliomamachine learningmultimodalprognosticationradiomics

Autor:innen und Institutionen

  • Chicago Medical School, Rosalind Franklin University of Science and Medicine, Chicago, IL 60064, USA.
  • Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

ORCID-Profile: Erik Knecht, Jonathan Huang, Michael DeCuypere

Zitieren

APA

Alleman, K., Knecht, E., Huang, J., Zhang, L., Lam, S., & DeCuypere, M. (2023). Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review. Cancers, 15(2), 545. https://doi.org/10.3390/cancers15020545

Vancouver

Alleman K, Knecht E, Huang J, Zhang L, Lam S, DeCuypere M. Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review. Cancers. 2023;15(2):545. doi:10.3390/cancers15020545

BibTeX
@article{Alleman2023,
  author = {Alleman, Kaitlyn and Knecht, Erik and Huang, Jonathan and Zhang, Lu and Lam, Sandi and DeCuypere, Michael},
  title = {Multimodal Deep Learning-Based Prognostication in Glioma Patients: A Systematic Review},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {545},
  doi = {10.3390/cancers15020545}
}
Kostenlos starten →